遺伝子増幅技術の世界市場：現状分析と予測（2022年～2028年）

世界の遺伝子増幅技術の市場規模は、2022年～2028年の予測期間中に約7％のCAGRを記録すると予想されています。

遺伝子増幅技術に対する需要の増加は、遺伝子検査、分子診断、およびゲノミクスの分野における研究開発の必要性の高まりに起因しています。また、様々な遺伝子増幅法に基づく多くの診断テストの開拓や、新規かつ先進的な製品のイントロダクション、個別化医療の受け入れが進んでいることも、市場成長の要因として挙げられます。さらに、政府の規制、シーケンスコストの低下、研究分野の活性化が成長を後押しすると予想されます。しかし、これらの技術にかかるコストが高いことや、ゲノム解読に関する認識が低いことなどの市場抑制要因が、市場成長の妨げとなっています。

当レポートでは、世界の遺伝子増幅技術市場について調査分析し、市場概要、セグメント別・地域別の市場分析、市場成長への影響因子、市場動向、競合情勢、主要企業プロファイルなどを提供しています。

目次

第1章 市場イントロダクション

第2章 調査手法と前提

第3章 市場概要

第4章 エグゼクティブサマリー

第5章 遺伝子増幅技術市場に対するCOVID-19の影響

第6章 世界の遺伝子増幅技術の市場収益（2020年～2028年）

第7章 市場の洞察：技術別

• PCRベースの増幅
• 複数の変位増幅
• 等温DNA増幅
• その他

第8章 市場の洞察：用途別

• 全ゲノム増幅
• エクソームシーケンシング
• SNPジェノタイピングアレイ
• アレイCGH
• ハイブリダイゼーション
• その他

第9章 市場の洞察：エンドユーザー別

• 病院・診療所
• 製薬およびバイオテクノロジー企業
• 学術研究機関
• その他

第10章 市場の洞察：地域別

• 北米
  • 米国
  • カナダ
  • その他北米
• 欧州
  • ドイツ
  • フランス
  • 英国
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • その他アジア太平洋
• 世界のその他地域

第11章 遺伝子増幅技術の市場力学

• 市場促進要因
• 市場の課題
• 影響分析

第12章 遺伝子増幅技術の市場機会

第13章 遺伝子増幅技術の市場動向と洞察

第14章 需要・供給分析

• 需要分析
• 供給分析

第15章 バリューチェーン分析

第16章 戦略的洞察

第17章 競合シナリオ

• 競合情勢
  • ポーターのファイブフォース分析

第18章 会社概要

• Qiagen NV
• New England Biolabs
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• BGI Genomics Co Ltd
• Oxford Nanopore Technologies PLC
• PerkinElmer, Inc.
• Becton Dickinson and Co
• Bayer AG
• Agilent Technologies Inc

第19章 免責事項

The gene amplification technologies market is expected to register a CAGR of approx. 7% over the period of 2022-2028. Gene amplification technology is a critical component of genomics that is widely used in diagnostics. For various studies, it assists in increasing the number of copies of a gene. Gene amplification is frequently carried out using dendritic polymers, transcription-mediated amplification, polymerase chain reaction to ligase chain reaction, and other methods. The main purpose of gene amplification technology is to compare the gene of the study sample with the genes of other germline or somatic cells. The growing demand for gene amplification technologies can be attributed to the expanding need for research and development in the fields of genetic testing, molecular diagnostics, and genomics which boosts the adoption of organic growth strategies among key industry players around the globe. For instance, in august 2022, QIAGEN launched new solutions that significantly accelerate DNA variant detection and RNA sequencing of low-input samples. QIAseq Targeted DNA Pro Panels are based on improved chemistry that halves to six hours the time researchers need for library preparation of DNA samples. Owing to the glaring statistics the increasing development of numerous diagnostic tests based on various gene amplification methods led to the growing demand for gene amplification technologies and would contribute to the growth of the market in the forthcoming period as well. In addition, the introduction of novel and advanced products and the growing acceptance of personalized medicine are likely to aid the market growth. Furthermore, the gene amplification technologies market is anticipated to grow on account of government regulations, decreasing sequencing costs together boosting the research field. However, some of the restraints in the market including the high costs of these technologies and limited awareness about genome sequencing are impeding the growth of this market all over the world.

Based on the technology, the gene amplification technologies market is segmented into PCR-based amplification, multiple displacement amplification, isothermal DNA amplification, and others. The PCR-based amplification segment accounted for a significant market share, and it is estimated that it will grow rapidly during the projected timeframe. PCR technology is widely used in a variety of end-use applications. Furthermore, the widespread use of PCR for COVID-19 detection has resulted in significant revenue generation by this technology.

Based on the application, the market is fragmented into whole genome amplification, exome sequencing, SNP genotyping arrays, array CGH, hybridization, and others. The hybridization segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. In the hybridization process, several multiplication technologies are increasingly being used.

Based on the end-users, the market is fragmented into hospitals & clinics, pharmaceutical & biotechnology companies, academic & research institutes, and others. The pharmaceutical & biotechnology companies segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. These businesses are concentrating on the creation of molecular diagnostic tests based on amplification techniques, which is promoting market expansion. Additionally, the market is expected to grow due to the expansion of applications in areas such as drug discovery, food quality control, bioremediation, and others.

For a better understanding of the market adoption of gene amplification technologies, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the gene amplification technologies industry owing to the presence of various genetic research programs in the region, as well as strong research and a commercial base for gene multiplication products, and growing funding by numerous government organizations in medical research and its infrastructure, which are the major factors contributing to the growth of the market.

Some of the major players operating in Qiagen NV; New England Biolabs; Illumina, Inc.; Bio-Rad Laboratories, Inc.; BGI Genomics Co Ltd; Oxford Nanopore Technologies PLC; PerkinElmer, Inc.; Becton Dickinson and Co; Bayer AG; AND Agilent Technologies Inc among others. Several M&A's along with partnerships have been undertaken by these players.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Gene Amplification Technologies Market
• 2.2. Research Methodology of the Gene Amplification Technologies Market
• 2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE GENE AMPLIFICATION TECHNOLOGIES MARKET

6 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY TECHNOLOGY

• 7.1. PCR-based Amplification
• 7.2. Multiple Displacement Amplification
• 7.3. Isothermal DNA Amplification
• 7.4. Others

8 MARKET INSIGHTS BY APPLICATION

• 8.1. Whole Genome Amplification
• 8.2. Exome Sequencing
• 8.3. SNP Genotyping Arrays
• 8.4. Array CGH
• 8.5. Hybridization
• 8.6. Others

9 MARKET INSIGHTS BY END-USERS

• 9.1. Hospitals & Clinics
• 9.2. Pharmaceutical & Biotechnology Companies
• 9.3. Academic & Research Institutes
• 9.4. Others

10 MARKET INSIGHTS BY REGION

• 10.1 NORTH AMERICA GENE AMPLIFICATION TECHNOLOGIES MARKET
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Rest of North America
• 10.2 EUROPE GENE AMPLIFICATION TECHNOLOGIES MARKET
  • 10.2.1 Germany
  • 10.2.2 France
  • 10.2.3 United Kingdom
  • 10.2.4 Spain
  • 10.2.5 Italy
  • 10.2.6 Rest of Europe
• 10.3 ASIA PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 Australia
  • 10.3.5 Rest of Asia Pacific
• 10.4 REST OF THE WORLD GENE AMPLIFICATION TECHNOLOGIES MARKET

11 GENE AMPLIFICATION TECHNOLOGIES MARKET DYNAMICS

• 11.1 Market Drivers
• 11.2 Market Challenges
• 11.3 Impact Analysis

12 GENE AMPLIFICATION TECHNOLOGIES MARKET OPPORTUNITIES

13 GENE AMPLIFICATION TECHNOLOGIES MARKET TRENDS & INSIGHTS

14 DEMAND AND SUPPLY SIDE ANALYSIS

• 14.1 Demand Side Analysis
• 14.2 Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 STRATEGIC INSIGHTS

17 COMPETITIVE SCENARIO

• 17.1. Competitive Landscape
  • 17.1.1 Porter's Five forces analysis

18 COMPANY PROFILED

• 18.1. Qiagen NV
• 18.2. New England Biolabs
• 18.3. Illumina, Inc.
• 18.4. Bio-Rad Laboratories, Inc.
• 18.5. BGI Genomics Co Ltd
• 18.6. Oxford Nanopore Technologies PLC
• 18.7. PerkinElmer, Inc.
• 18.8. Becton Dickinson and Co
• 18.9. Bayer AG
• 18.10. Agilent Technologies Inc

19 DISCLAIMER